Medi-Caps (NSE:MEDICAPQ) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDICAPQ Medi-Caps Ltd NSE:MEDICAPQ
41 GF Score
Price ₹23.56
GF Value ₹19.30
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Medi-Caps FFO?

FFO (Funds from operations) only applies to REITs.

NSE:MEDICAPQ
41GF Score
Medi-Caps Ltd NSE:MEDICAPQ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medi-Caps (NSE:MEDICAPQ) Overvalued in 2026?

Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued. The current stock price of ₹23.56 is trading 22.1% above its estimated GF Value™ of ₹19.30. GuruFocus considers Medi-Caps to be Modestly Overvalued.

Key valuation signals for NSE:MEDICAPQ:

  • FFO:
  • GF Value™: ₹19.30 vs. price of ₹23.56 (22.1% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the NSE:MEDICAPQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medi-Caps Business Description

Comparable Companies
Other Exchanges 523144:India
Address 201, Pushpratna Paradise, 9/5, New Palasia, Opposite UCO Bank, Indore, MP, IND, 452 001
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
41GF Score

Get the complete analysis for NSE:MEDICAPQ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.56
Price
₹19.30
GF Value